CMS 2021 Proposed Rules: Changes, Conversion Factor and Cuts: 
What LUGPA Practices Need to Know

August 18, 2021 
5:00 – 6:00 PM Eastern Time

THIS WEBINAR IS NOW AVAILABLE ON DEMAND HERE [Member Login Required] 

In the past month, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that announces and solicits public comments on proposed policy changes for Medicare payments under the Physician Fee Schedule (PFS), the Outpatient Prospective Payment System (OPPS), and the interim final rule on surprise billing.  All three rules will become effective January 1, 2022.

Under the proposed rule some of the key changes that impact urology practices include reductions in Medicare conversion factor, polices that effect E/M code sets, and changes to ambulatory surgery centers, telehealth services, and to the Merit-based Incentive Payment System.

This webinar will discuss and clarify the proposed rules as they relate to the independent urology practice, LUGPA advocacy efforts, and address LUGPA member concerns about the policy changes.

Moderator: Scott B. Sellinger, MD
LUGPA Secretary and Chair, LUGPA Program Committee
President, Advanced Urology Institute

Panelists:

Thomas Barker, JD
Partner, Foley Hoag, and Co-Chair Healthcare Practice
Adjunct Professor of Health Law, George Washington University School of Law and School of Public Health and Health Services

Mara R. Holton, MD
Vice-Chair, LUGPA Health Policy Committee
Founder and Director, Women’s Wellness Center
at Anne Arundel Urology

Deepak A. Kapoor, MD
Chair, LUGPA Health Policy Committee
Chairman and Chief Ecosystem Officer, Solaris Health Holdings, LLC
Clinical Professor of Urology, The Icahn School
of Medicine at Mount Sinai

FACULTY BIOGRAPHIES

Thomas Barker
Partner, Co-Chair, Healthcare Practice - Washington, D.C.

Thomas Barker has been a partner at Foley Hoag since March of 2009. Tom focuses his practice on complex federal and state health care legal and regulatory matters with a special expertise in Medicare and Medicaid law including coverage, reimbursement, and regulatory oversight. In May of 2019, he was appointed as a commissioner of the Medicaid and CHIP Payment and Access Commission (MACPAC), an advisory body that provides policy advice to Congress and the states on the

Medicaid and CHIP programs. He is one of the authors of the firm's Medicaid & the Law blog, www.medicaidandthelaw.com, which highlights and explains current legal and policy issues in the Medicaid program.

Prior to joining the firm, he was acting General Counsel of the U.S. Department of Health and Human Services (HHS) and General Counsel of the Centers for Medicare & Medicaid Services (CMS).

 Mara R. Holton, MD
Founder and Director, Women’s Wellness Center at Anne Arundel Urology

Dr. Mara Holton graduated from Temple University School of Medicine in 2001. She received her surgical and urology training at the University of Maryland Medical Center. She is certified by the American Board of Urology and is licensed in the state of Maryland. She is clinically focused on the care of women’s urological and pelvic floor health and has served as the CEO of her group, Anne Arundel Urology, for the past 4 years. She is a Board member of LUGPA, a member of the American Urological Association and is the founder and director of the Women’s Wellness Center at Anne Arundel Urology.

Deepak A. Kapoor, MD

Deepak A. Kapoor, Chairman and Chief Ecosystem Officer of Solaris Health Holdings, LLC, is one of the youngest physicians to have been certified by the American Board of Urology.  In addition to his role at Solaris Health, Dr. Kapoor serves as Market President for Integrated Medical Professionals, PLLC (IMP) and is President of Advanced Urology Centers of New York.

Dr. Kapoor received his baccalaureate and medical education with honors in the Pennsylvania State University/Jefferson Medical College accelerated honors program in medicine and completed his urologic residency at The Geisinger Medical Center in Danville, PA. His expertise includes basic science research in molecular biology, as well as extensive experience in oncologic and reconstructive surgery.

Dr. Kapoor is Clinical Professor of Urology at the Icahn School of Medicine at Mount Sinai, Chair of Health Policy and Past President of LUGPA, Chairman of SCRUBS RRG and Senior Strategic Advisor for miR Scientific. He has also served as a Director of UroPAC and Chairman of Access to Integrated Cancer Care. Dr. Kapoor was founder of the New York Urology Trade Association and Integrated Medical Foundation. He is a Fellow of the American College of Physician Executives.

Dr. Kapoor has published and lectured extensively on clinical, business and health policy issues and is Associate Editor of the journal Urology Practice. He serves on a number of medical advisory boards, including the New York State Governor´s Prostate Cancer Advisory Panel. Dr. Kapoor has been continuously listed in the Castle Connolly Best Doctors Guide for his clinical excellence and has received numerous accolades, including the 2011 AUA Ambrose-Reed socioeconomic essay award, and the 2014 New York Section AUA Russell W. Lavengood distinguished service award.  Dr. Kapoor was recognized in 2018 by LUGPA for his outstanding contributions to health policy and his work towards the preservation of independent medicine.

Scott Sellinger, MD

Dr. Sellinger has been a partner at Southeastern Urological Center, now a division of Advanced Urology Institute, for the past 27 years. He received his BS degree in Chemistry from Syracuse University and attended Medical School at the University of Florida in Gainesville. He completed his Urology residency at the University of Florida and has lived in Tallahassee since 1991. He was President of the Capital Medical Society in 2003 and served as President of the Florida Urological Society in 2005. In March 2018, he became President of the Southeastern Section of the AUA, where he has been an active board member since 2001.

Dr. Sellinger has developed a special interest in risk management and prevention of medical errors and has lectured extensively on this subject matter over the past several years. He is also interested in large group practice development and management. As President of Southeastern Urological Center in Tallahassee, he serves on the Board of Advanced Urology Institute, representing his care center in one of the largest independent urology practices in the US. He is Chairman of the Advanced Prostate Cancer (APC) Committee and oversees five APC clinics. At the national level, Dr. Sellinger serves on the AACU Board as well as the LUGPA Board of Directors, as Secretary. At LUGPA, he helps represent over 2300 Urologists by working to preserve and advance the independent practice of urology.